AS160 controls eukaryotic cell cycle and proliferation by regulating the CDK inhibitor p21

Pianchou Gongpan1,2, Yanting Lu1,2, Fang Wang1,2

  • 1a State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany , Chinese Academy of Sciences , Kunming , Yunnan , P.R. China.

Insights

AS160 (TBC1D4) regulates cell proliferation independently of glucose by controlling the cell cycle via p21. This study reveals a key mechanism for AS160 in cell cycle and proliferation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • AS160 (TBC1D4) is involved in various biological processes.
  • Its precise role in regulating cell proliferation and its mechanism of action are not fully understood.

Purpose of the Study:

  • To elucidate the role and mechanism of AS160 in regulating eukaryotic cell proliferation.
  • To investigate the relationship between AS160, cell cycle, and the cyclin-dependent kinase inhibitor p21.

Main Methods:

  • AS160 knockdown and overexpression in fibroblasts and cancer cells.
  • Cell cycle analysis using flow cytometry.
  • Western blotting to assess p21 and AS160 expression levels.
  • p21 silencing experiments.

Main Results:

  • AS160 depletion inhibited cell proliferation and caused G1 phase cell cycle arrest in a glucose-independent manner.
  • AS160 silencing led to increased p21 expression.
  • AS160 overexpression decreased p21 levels and rescued cell cycle arrest.
  • p21 silencing rescued proliferation and cell cycle progression in AS160-depleted cells.

Conclusions:

  • AS160 regulates glucose-independent cell proliferation through p21-dependent cell cycle control.
  • This study reveals a novel molecular mechanism for AS160 in modulating cell cycle and proliferation with broad physiological relevance.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K